A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk
about
Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasisSolution structure of the oncogenic MIEN1 protein reveals a thioredoxin-like fold with a redox-active motifAn in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer.A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell linesGnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.Mouse mammary tumor virus molecular biology and oncogenesisMicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.Long-term culture of human breast cancer specimens and their analysis using optical projection tomography.MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.MIEN1 promotes oral cancer progression and implicates poor overall survival.Characterising the tumour morphological response to therapeutic intervention: an ex vivo model.Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cellsMIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamicsEnhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.The Transcriptional Landscape of p53 Signalling PathwayAncestry as a potential modifier of gene expression in breast tumors from Colombian women.Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells.Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum-Implications for the Choice of Circulating Tumour DNA Methylation Markers
P2860
Q24305028-27CA7196-E72A-4FAF-8D88-1886CEA8C1DDQ28484489-188CC1CF-8CEB-4592-AF88-7F251C7A93E3Q33828295-7A0A87F9-3DB5-4272-9984-5EA8364CA8A6Q34010823-CB8E7A7B-036C-415C-8AD1-CF3B40AF0CADQ34066386-27B16BAB-A826-4CCD-BC10-E255F419C8CFQ34161161-9698C5F9-E66B-41E9-AD90-42700E7FAC7DQ34582195-46699679-ED25-46E1-AFE7-A2A377A72B86Q34625171-F3A57425-4F8E-44FB-A476-B751D0567A2CQ35396741-FFD86B93-3095-4035-B32C-7559309FAF59Q35953723-478EDF6E-D5F8-404B-B95C-83020598AB68Q36214196-3B8DB19F-9668-4DDC-8B0F-C1424471FC11Q36486054-B72DB436-11FC-4832-89B0-82A89B6DB692Q36758884-F00C9BF0-6DF3-4D57-BAA0-E5B46C319896Q37111154-8C3B18A2-0A6D-40DA-8D01-4C19AB1D7382Q37688163-4322734E-B96F-427F-909D-CD6C9F3E3949Q38949355-7C2C0138-3335-42B1-8694-3196E2B83A83Q39557228-6E6E6FBB-08A8-44ED-9E70-9553F0C1D024Q39586702-1BC58646-C3DE-45E7-80CF-035740B4DD73Q41084526-6406CB20-A4A2-4E9A-9E7D-23F3600759F7Q41498719-8BF8341F-F7C8-4CD7-96D5-79CDCF3BB6E1Q41577652-6C79B8ED-0DC0-41E0-AC78-BAA79438D983Q51136450-BFFB5554-E1DC-4F02-AA69-FB0FA4C83044Q55342016-06E5E2EF-A5F8-4307-95ED-770D2BF335A9Q57390777-91D8375D-0E72-43BE-AD29-3DF22CB2DC3F
P2860
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A gene on the HER2 amplicon, C ...... prevented by inhibition of Syk
@ast
A gene on the HER2 amplicon, C ...... prevented by inhibition of Syk
@en
type
label
A gene on the HER2 amplicon, C ...... prevented by inhibition of Syk
@ast
A gene on the HER2 amplicon, C ...... prevented by inhibition of Syk
@en
prefLabel
A gene on the HER2 amplicon, C ...... prevented by inhibition of Syk
@ast
A gene on the HER2 amplicon, C ...... prevented by inhibition of Syk
@en
P2093
P2860
P50
P356
P1476
A gene on the HER2 amplicon, C ...... prevented by inhibition of Syk
@en
P2093
D Faratian
S Dubois-Marshall
S P Langdon
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605763
P407
P577
2010-07-13T00:00:00Z
P5875
P6179
1000694874